These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Enhanced expression of ICAM-1 in a murine fibrosarcoma reduces tumor growth rate. Sartor WM; Kyprianou N; Fabian DF; Lefor AT J Surg Res; 1995 Jul; 59(1):66-74. PubMed ID: 7630139 [TBL] [Abstract][Full Text] [Related]
6. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123 [TBL] [Abstract][Full Text] [Related]
7. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation. Begovic M; Herberman R; Gorelik E Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641 [TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes cultured in recombinant interleukin-2: enhancement of growth, cytotoxicity, and phenotypic expression of cytotoxic T-cell antigens by cyclophosphamide given intravenously prior to tumor harvest. Lafreniere R; Borkenhagen K; Bryant LD; Ng E J Biol Response Mod; 1989 Jun; 8(3):238-51. PubMed ID: 2787392 [TBL] [Abstract][Full Text] [Related]
9. Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures. Topalian SL; Kasid A; Rosenberg SA J Immunol; 1990 Jun; 144(11):4487-95. PubMed ID: 2160503 [TBL] [Abstract][Full Text] [Related]
10. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation. Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells. Wallace PK; Palmer LD; Perry-Lalley D; Bolton ES; Alexander RB; Horan PK; Yang JC; Muirhead KA Cancer Res; 1993 May; 53(10 Suppl):2358-67. PubMed ID: 8485722 [TBL] [Abstract][Full Text] [Related]
12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
13. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes. Itoh T; Storkus WJ; Gorelik E; Lotze MT J Immunol; 1994 Aug; 153(3):1202-15. PubMed ID: 7517974 [TBL] [Abstract][Full Text] [Related]
14. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells. Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816 [TBL] [Abstract][Full Text] [Related]
15. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells. Tanaka Y; Mine S; Hanagiri T; Hiraga T; Morimoto I; Figdor CG; van Kooyk Y; Ozawa H; Nakamura T; Yasumoto K; Eto S Cancer Res; 1998 Sep; 58(18):4138-45. PubMed ID: 9751626 [TBL] [Abstract][Full Text] [Related]
16. Interaction of tumor-infiltrating lymphocyte from oral squamous cell carcinoma with FN enhances its adhesion and cytotoxicity. Yang H; Li J; Zhao Y; Li Z Chin J Dent Res; 1999 Dec; 2(3-4):49-53. PubMed ID: 10863417 [TBL] [Abstract][Full Text] [Related]
17. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity. Yang X; Chu Y; Wang Y; Zhang R; Xiong S J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511 [TBL] [Abstract][Full Text] [Related]
18. [Tumor infiltrating lymphocytes inhibit spontaneous lung metastasis of LA795 adenocarcinoma in mice]. Shen YQ; Lai BT; Wang H Zhonghua Jie He He Hu Xi Za Zhi; 1994 Jun; 17(3):165-7, 191. PubMed ID: 7834774 [TBL] [Abstract][Full Text] [Related]
19. [The effect of anti-ICAM-1/LAF-1 McAb on the cytotoxicity of tumor infiltrating lymphocytes from oral squamous cell carcinoma]. Yang H; Luo J; Li J Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):107-8, 111. PubMed ID: 12838691 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]